Moleculin says Annamycin preclinical data show CD8+ T cell — mediated activity in pancreatic cancer models
Moleculin Biotech disclosed new preclinical pancreatic cancer data on Annamycin, presented at the AACR Conference on Pancreatic Cancer. Findings suggest the drug’s antitumor effect is partly driven by CD8+ T cells, indicating potential to make “cold” tumors more immune-responsive. The results support a possible combina